Adlai Nortye Group Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
15.62
+0.11 (0.71%)
At close: Oct 9, 2026, 4:00 PM EDT
16.70
+1.08 (6.91%)
After-hours: Oct 9, 2026, 7:30 PM EDT
Adlai Nortye Group Employees
Adlai Nortye Group had 109 employees as of December 31, 2025. The number of employees decreased by 14 or -11.38% compared to the previous year. That makes Adlai Nortye Group the 30,859th largest employer in the world and 3,948th in the United States.
Employees
109
Change (1Y)
-14
Growth (1Y)
-11.38%
Revenue / Employee
$165,651
Profits / Employee
-$206,688
Market Cap
1.01B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 109 | -14 | -11.38% |
| Dec 31, 2024 | 123 | -4 | -3.15% |
| Dec 31, 2023 | 127 | -2 | -1.55% |
| Jun 30, 2023 | 130 | - | - |
| Mar 31, 2023 | 129 | - | - |
| Dec 31, 2022 | 129 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MannKind | 592 |
| MeiraGTx Holdings | 393 |
| Janux Therapeutics | 113 |
| Cullinan Therapeutics | 109 |
| Alto Neuroscience | 68 |
| Seaport Therapeutics | 58 |
| Avalyn Pharma | 55 |
ANL News
- 9 days ago - Adlai Nortye appoints Liu as Head of Investor Relations, Public Relations - TheFly
- 9 days ago - Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations - GlobeNewsWire
- 23 days ago - Adlai Nortye Group Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Adlai Nortye initiated with a Buy at Jefferies - TheFly
- 4 weeks ago - Adlai Nortye doses first patient in AN4035 trial - TheFly
- 4 weeks ago - Adlai Nortye Announces First Patient Dosed in Australia and U.S. FDA IND Clearance for AN4035, a First-in-Class Pan-RAS(ON) Inhibitor-Based ADC - GlobeNewsWire
- 4 weeks ago - Adlai Nortye assumed with a Buy at Lucid Capital - TheFly
- 1 month ago - Adlai Nortye Group Earnings release: Q2 2026 - Filings